- Active not recruitingPHASE2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
This study looks at the long-term safety and effectiveness of a new medicine called verekitug (UPB-101) for adults with severe asthma. It's for people who have already finished a related study called VALIANT.
For: Severe AsthmaUnited States · Argentina · Bulgaria - RecruitingPHASE2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
This study is testing a new medicine, Verekitug, for people with moderate to severe COPD. It will check how well the medicine works and if it's safe. Participants will take Verekitug or a dummy pill alongside their usual COPD treatments.
For: Chronic Obstructive Pulmonary DiseaseUnited States · Argentina · Bulgaria